The Board of Directors of Orion Corporation decided on a new plan period for the Long-term Incentive program for the company’s key persons

Core Viewpoint - Orion Corporation has established a new Long-term Incentive Program for key personnel, aiming to align the interests of shareholders and key individuals to enhance company value and provide competitive rewards based on share performance [1][2]. Group 1: Long-term Incentive Program Details - The Long-term Incentive Program includes performance share plans launched annually, with a three-year earning period for participants to earn class B shares [1]. - The new plan period for the program is set for the calendar years 2026-2028, with the first plan launched in 2025 covering 2025-2027 [2]. - The maximum reward for the 2026-2028 period is capped at 420,000 class B shares, with a total estimated cost of MEUR 26.5 based on share price averages prior to the plan's launch [4]. Group 2: Performance Criteria and Reward Structure - Rewards will be determined based on the achievement of targets related to operating profit, net sales, pipeline and portfolio development, and ESG performance [3]. - The total reward is limited to three times the participant's annual base salary, with a portion paid in cash to cover tax liabilities [5]. Group 3: Company Overview - Orion Corporation is a Nordic pharmaceutical company with over a century of experience, focusing on human and veterinary pharmaceuticals, including proprietary and generic medicines [7]. - In 2025, Orion's net sales reached EUR 1,890 million, and the company employs approximately 4,000 professionals globally [7].